MK-677 (25mg per ml x 30ml)

MK-677 (also known as “Ibutamoren”) is a small-molecule compound studied in the scientific literature as an orally active growth hormone secretagogue. In research contexts, it is primarily discussed for its interaction with the ghrelin receptor (also referred to as the growth hormone secretagogue receptor, GHSR1a) and downstream effects on growth hormone (GH) pulsatility and insulin-like growth factor 1 (IGF‑1) signaling pathways. Investigations have examined MK-677 in preclinical models and limited clinical-study settings for endocrine biomarkers, metabolic endpoints, and sleep-related measures, but it is not established as safe or effective for general human use outside approved clinical frameworks.

RESEARCH APPLICATIONS (Preclinical / Mechanistic)

Scientific investigations have explored MK-677 for:

• GHSR1a (ghrelin receptor) binding and agonism assays
• GH pulsatility and endocrine biomarker studies (research settings)
• IGF‑1 pathway signaling and downstream gene-expression research
• Appetite/energy balance signaling models (ghrelin-axis studies)
• Sleep architecture and neuroendocrine coupling research (experimental contexts)
• Metabolic biomarker research (e.g., glucose/insulin dynamics in models)
• Body composition endpoints in controlled-study settings (research endpoints)
• Off-target pharmacology screening (receptor panels)
• ADME/PK characterization (absorption, metabolism, clearance in models)
• Toxicology and safety pharmacology screening in preclinical settings

MECHANISM OF ACTION (Research Context)

MK-677 is generally characterized as a ghrelin receptor (GHSR1a) agonist:

• Primary target: GHSR1a (ghrelin receptor / growth hormone secretagogue receptor)
• Putative action: Mimics ghrelin-like signaling, promoting GH release patterns
• Downstream effects studied: Modulation of GH/IGF‑1 axis biomarkers and related signaling cascades that influence growth, metabolism, and tissue remodeling
• Systems considerations: Endocrine effects can interact with appetite regulation, glucose homeostasis, fluid balance, and sleep-related neuroendocrine pathways

QUALITY / IDENTITY VERIFICATION (Analytical)

For research-grade chemical identity confirmation and documentation, common analytical approaches include:

• LC‑MS/HRMS for molecular ion confirmation and impurity profiling
• NMR (¹H/¹³C) for structural confirmation where applicable
• HPLC/UPLC assay for purity and related substances
• Residual solvent analysis (GC) where applicable
• Water content determination (e.g., Karl Fischer) depending on form
• Stability testing under defined storage conditions
• Batch documentation practices (lot ID, COA linkage, chain-of-custody where relevant)